Clinical Trials Browser

Terminated × Carcinoma, Hepatocellular × Arsenic Trioxide × Clear all

NCT00582400 2016-02-19

A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver

Phase 2 Terminated

9 enrolled 7 charts

Gastrointestinal

Carcinoma, Hepatocellular